Table 1 of Pauly, Mol Vis 2011; 17:745-755.


Table 1. Benzalkonium chloride (BAC) and active compound content of the antiallergic eye drops tested.



Eye drops
Active
compound
content

BAC
content
Ketotifen fumarate (Zaditen®; Novartis Pharma SAS,Rueil-Malmaison, France) 0.025% 0.01%
Olopatadine chlorhydrate (Opatanol®; Patanol®; Alcon, Ft. Worth, TX) 0.1% 0.01%
Epinastine chlorhydrate (Purivist®; Allergan, Irvin, CA) 0.05% 0.01%
Levocabastine chlorhydrate (Levophta®; Chauvin Bausch & Lomb, Montpellier, France) 0.05% 0.015%
Preservative-free ketotifen fumarate (Zalerg®; Thea, Clermont-Ferrand, France) 0.025% -
Preservative-free NAAGA (NAABAK®; Thea, Clermont-Ferrand, France) 4.9% -
Preservative-free sodium cromoglycate (Cromabak®; Thea, Clermont-Ferrand, France) 2% -